OncoCyte (OCX) Stock Chart & Stock Price History $3.42 +0.35 (+11.40%) As of 02:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OncoCyte Stock Price Performance The OncoCyte (OCX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 17.53%, with a year-to-date return of 43.70%. In the past month, the stock has increased 17.12%, reflecting recent market activity. As of the latest close, OncoCyte traded at $3.07 with a market cap of $87.80 million and volume of 26,849 shares. Five years ago, the stock traded at a split-adjusted price of $49.80, representing a 93.13% decrease over that period. At the time, it had a market cap of $190.90 million and a volume of 19,540 shares. Receive OCX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+22.58%1 Month Performance+17.12%3 Month Performance+29.06%Year-To-Date Performance+43.70%1 Year Performance+17.53%5 Year Performance-93.13% OCX Stock Chart for Thursday, May, 22, 2025 OCX Chart by TradingView OncoCyte Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$2.94$3.07+4.42%$3.08$2.8326,849 shs$87.80 million05/20/2025$2.80$2.94+5.00%$3.07$2.6466,970 shs$84.08 million05/19/2025$2.79$2.80+0.36%$2.94$2.6516,834 shs$80.08 million05/16/2025$2.79$2.79$2.98$2.7552,664 shs$79.79 million05/15/2025$2.60$2.79+7.31%$2.86$2.6034,447 shs$79.79 million05/14/2025$2.77$2.60-6.14%$2.74$2.6018,746 shs$74.36 million05/13/2025$2.81$2.77-1.42%$2.82$2.5749,582 shs$79.22 million05/12/2025$2.87$2.81-2.09%$3.06$2.6464,472 shs$80.36 million05/09/2025$2.83$2.87+1.41%$2.96$2.8162,571 shs$82.08 million05/08/2025$2.83$2.83+0.07%$2.89$2.7922,752 shs$80.94 million Get the Latest News and Ratings for OCX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$2.89$2.83-2.15%$2.94$2.7826,673 shs$80.88 million05/06/2025$2.92$2.89-1.03%$3.32$2.80141,220 shs$82.65 million05/05/2025$3.03$2.92-3.63%$3.11$2.8915,015 shs$83.51 million05/02/2025$3.10$3.03-2.26%$3.10$3.0013,235 shs$86.66 million05/01/2025$3.08$3.10+0.65%$3.18$2.8743,070 shs$88.66 million04/30/2025$3.12$3.08-1.28%$3.25$3.0861,598 shs$88.09 million04/29/2025$3.22$3.12-3.11%$3.35$3.1019,472 shs$89.23 million04/28/2025$3.44$3.22-6.40%$3.44$3.1924,160 shs$92.09 million04/25/2025$3.39$3.44+1.47%$3.50$3.2688,149 shs$98.38 million04/24/2025$2.95$3.39+14.92%$3.44$3.05169,400 shs$96.95 million04/23/2025$2.92$2.95+1.03%$3.03$2.8228,043 shs$84.37 million04/22/2025$2.88$2.92+1.39%$3.08$2.7882,068 shs$83.51 million04/21/2025$2.84$2.88+1.41%$2.92$2.787,789 shs$82.37 million Related Companies Arcturus Therapeutics Stock Price Chart Heron Therapeutics Stock Price Chart Septerna Stock Price Chart Benitec Biopharma Stock Price Chart Fulcrum Therapeutics Stock Price Chart Atyr PHARMA Stock Price Chart Atai Life Sciences Stock Price Chart Aurora Cannabis Stock Price Chart Aquestive Therapeutics Stock Price Chart Compass Therapeutics Stock Price Chart Receive OCX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OCX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoCyte Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share OncoCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.